AXGN Q3 2022 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$37M+18.4% YoY

Gross Profit

$31M83.3% margin

Operating Income

-$5M-13.1% margin

Net Income

-$4M-11.7% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

-$689,000

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$196M

Total Liabilities

$94M

Stockholders' Equity

$101M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$31M	+18.4%
Gross Profit	$31M	$26M	+18.6%
Operating Income	-$5M	-$7M	+27.4%
Net Income	-$4M	-$7M	+39.5%